Last update Nov. 1, 2012
Very High Risk
Ergot-derivative alkaloid with an inhibiting effect on prolactin and dopamine release, used for treatment of prolactinoma, Parkinson’s Disease, brain vascular insufficiency and senile dementia. It may suppress lactation by inhibiting prolactin release.
We do not have alternatives for Dihydroergocryptyne Mesilate.
Suggestions made at e-lactancia are done by APILAM team, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.